Pathologic and Virologic Characterization of Neuroinvasion by HSV-2 in a Mouse Encephalitis Model

被引:3
作者
Allavena, Rachel E.
Desai, Bhavika
Goodwin, David
Khodai, Tansi
Bright, Helen [1 ]
机构
[1] Pfizer Global Res & Dev, Infect Dis Grp, Sandwich, Kent, England
关键词
Encephalitis; Herpes simplex virus 2; Intranasal; Mouse; Pathology; HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; TYPE-2; INFECTION; MICE; INOCULATION; SPREAD; EPIDEMIOLOGY; ACYCLOVIR; PREGNANCY; ANTIGEN;
D O I
10.1097/NEN.0b013e3182275264
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Herpes simplex virus type 2 (HSV-2), a ubiquitous human pathogen associated with genital infections, is neurotropic. It establishes latent infections in local dorsal root ganglia from which it reactivates causing recurrent lesions and frequent episodes of viral shedding. Herpes simplex virus type 2 can also be transmitted from mother to child during birth, causing major neonatal complications including encephalitis. Animal models of HSV-2 genital infection are well described and used for testing of therapies; little is known about animal models of HSV-2-induced encephalitis. We analyzed the pathologic and immunohistochemical features of the nasal rostrum and brain tissue and correlated them with viral distribution in a mouse model of HSV-2 encephalitis induced by intranasal infection and examined viral replication in the brain tissue using quantitative polymerase chain reaction and traditional plaque assay. Our results suggest that the primary route for HSV-2 neuroinvasion after intranasal infection is via the trigeminal pathway, ultimately leading to infection of the brainstem and meningoencephalitis.
引用
收藏
页码:724 / 734
页数:11
相关论文
共 38 条
  • [21] Johnson RT, 1996, CLIN INFECT DIS, V23, P225
  • [22] Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model
    Jones, CA
    Taylor, TJ
    Knipe, DM
    [J]. VIROLOGY, 2000, 278 (01) : 137 - 150
  • [23] Redundancy in the immune system restricts the spread of HSV-1 in the central nervous system (CNS) of C57BL/6 mice
    Kastrukoff, Lorne F.
    Lau, Allen S.
    Takei, Fumio
    Smyth, Mark J.
    Jones, Claerwen M.
    Clarke, Sally R. M.
    Carbone, Francis R.
    [J]. VIROLOGY, 2010, 400 (02) : 248 - 258
  • [24] KERN E, 1999, ANIMAL MODELS CENTRA
  • [25] OPTIMAL TREATMENT OF HERPES-SIMPLEX VIRUS ENCEPHALITIS IN MICE WITH ORAL ACYCLOVIR
    KERN, ER
    RICHARDS, JT
    GLASGOW, LA
    OVERALL, JC
    DEMIRANDA, P
    [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (1A) : 125 - 131
  • [26] ACYCLOVIR TREATMENT OF DISSEMINATED HERPES-SIMPLEX VIRUS TYPE-2 INFECTION IN WEANLING MICE - ALTERATION OF MORTALITY AND PATHOGENESIS
    KERN, ER
    RICHARDS, JT
    OVERALL, JC
    [J]. ANTIVIRAL RESEARCH, 1986, 6 (04) : 189 - 195
  • [27] Kumar V, 2005, Robbins and cotran pathologic basis of disease
  • [28] ALTERATION OF INTRACEREBRAL CYTOKINE PRODUCTION IN MICE INFECTED WITH HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2
    LEWANDOWSKI, G
    HOBBS, MV
    BLOOM, FE
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1994, 55 (01) : 23 - 34
  • [29] Brainstem encephalitis: an unusual presentation of herpes simplex virus infection
    Livorsi, Daniel
    Anderson, Eric
    Qureshi, Sakib
    Howard, Marion
    Wang, Yun F.
    Franco-Paredes, Carlos
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 (09) : 1432 - 1437
  • [30] An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
    Looker, Katharine J.
    Gamett, Geoffrey P.
    Schmid, George P.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2008, 86 (10) : 805 - 812